birdrock, thank God Denner won the proxy contest after glancing through the financials I want to throw up.
They are working on the combo pill.
We are also advancing our fixed-dose combination (FDC) program for icosapent ethyl, which will improve the future value, penetration and long-term
value of our VASCEPA/VAZKEPA franchise in Europe. We see significant opportunities for our FDC portfolio to impact the product lifecycle in the
marketplace, while offering patients greater convenience and driving increased adherence.
News 
Market Data 
Discover 
